Alaska Legislature Raise Minimum Age and Imposes E-cig Consumption Tax

Regulations by 2FIRSTS.ai
Mar.06.2024
Alaska Legislature Raise Minimum Age and Imposes E-cig Consumption Tax
Alaska Legislature proposes bill to raise tobacco and e-cigarette age to 21, impose 25% sales tax on e-cigarettes.

According to reports from KTUU media, the Alaska state legislature is taking action by passing a law to address concerns about children using e-cigarettes.

 

Alaska Governor Mike Dunleavy vetoed a bill in 2022 that would have raised the minimum age for purchasing tobacco products and e-cigarette devices, as well as imposed a sales tax on e-cigarette devices. Senator Gary Stevens introduced SB 89 to the House Labor and Commerce Committee in 2023, proposing to raise the minimum age for purchasing, selling, or possessing tobacco products and e-cigarette devices to 21, and impose a 25% sales tax on e-cigarette products.

 

The Alaskan Legislature is once again attempting to pass a law to address public concerns over the long-term health effects of children's early smoking, particularly with the use of e-cigarette devices.

 

In fact, the bill was passed by both the House and Senate in 2022, but was vetoed by Governor Mike Dunleavy. The bill was originally intended to raise the minimum age for purchasing tobacco products and impose sales taxes on e-cigarette devices.

 

In 2023, Senator Gary Stevens introduced the SB 89 bill to the House Committee on Labor and Commerce. He stated, "We have delayed addressing this issue for too long. It is time to confront this new industry and tackle the lifelong addiction faced by young Alaskans.

 

This proposal will align with federal law by raising the minimum age for purchasing, selling, or possessing tobacco products and e-cigarette products from 19 to 21 years old, while imposing a 25% sales tax on e-cigarette products. A previous bill that included a sales tax of up to 35% on e-cigarette products was rejected.

 

Deng Liwei explained his decision to veto the bill, stating, "There have been many discussions about how to tax, but ultimately I cannot support increasing the tax burden on the people of Alaska."

 

However, Stevens stated, "Taxes have been proven to reduce the tobacco use among teenagers, decrease the likelihood of children becoming lifelong smokers, thereby ultimately lowering healthcare costs."

 

Emily Nenon, the government relations manager from the American Cancer Society Cancer Action Network in Alaska, agrees with Stevens' viewpoint, stating, "E-cigarettes are increasingly being accessed by young people, and raising prices is the best way to deter children from starting to use these products."

 

Opposing the change, Senator Mike Shower asked, "You're old enough to carry a gun and old enough to die for your country, but not old enough to drink? To smoke a cigarette? To use an e-cigarette?"

 

If the bill passes the Labor and Commerce Committee, it will move on to the House Finance Committee for consideration. The bill was approved by the Senate in May 2023 with a vote of 14 to 6.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22